Related Experiment Video
Updated: Aug 24, 2025

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
Restrictive cardiomyopathy: definition and diagnosis
Claudio Rapezzi1,2, Alberto Aimo3,4, Andrea Barison3,4
1Cardiologic Centre, University of Ferrara, Via Savonarola, 9, 44121 Ferrara, Italy.
Restrictive cardiomyopathy (RCM) involves stiff heart muscle, causing pressure buildup. Diagnosis uses various imaging and tests, with limited disease-modifying treatments available.
Area of Science:
- Cardiology
- Cardiovascular Diseases
- Heart Failure
Background:
- Restrictive cardiomyopathy (RCM) is defined by increased myocardial stiffness leading to rapid ventricular pressure rise.
- Key features include persistent restrictive pathophysiology, diastolic dysfunction, and non-dilated ventricles with atrial dilatation.
- RCM presents a wide phenotypic spectrum, complicating classification.
Purpose of the Study:
- To elucidate the heterogeneous nature of restrictive cardiomyopathy.
- To outline the classification of RCM based on underlying disease mechanisms.
- To review diagnostic modalities and current therapeutic limitations.
Main Methods:
- Cardiac catheterization and Doppler echocardiography demonstrate restrictive pathophysiology.
- Diagnosis relies on clinical data, ECG, echocardiography, nuclear medicine, and cardiovascular magnetic resonance.
- Further investigations may include endomyocardial biopsy and genetic evaluation.
Main Results:
- RCM is classified into four mechanisms: fibrosis, infiltration, storage material accumulation, and endomyocardial fibrosis.
- Phenotypes can evolve, with some disorders showing restrictive pathophysiology only at specific stages.
- Coexisting hypertrophic and restrictive phenotypes present classification challenges.
Conclusions:
- Restrictive cardiomyopathy is a complex condition with diverse etiologies and presentations.
- Diagnostic approaches are multi-modal, requiring advanced investigations in some cases.
- Effective disease-modifying therapies are currently limited, primarily for cardiac amyloidosis and iron overload cardiomyopathy.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease I: Introduction

